VOR – vor biopharma inc. (US:NASDAQ)

News

Vor Biopharma (VOR) was upgraded by Wall Street Zen from "strong sell"
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Biopharma (VOR) had its price target raised by Wedbush from $9.00 to $15.00. They now have a "neutral" rating on the stock.
Vor Biopharma (VOR) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Vor Biopharma (VOR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com